Regeneron Pharmaceuticals, Inc. (BVMF:REGN34)

Regeneron Pharmaceuticals Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 22, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	443,902	474,006	453,222	407,367	367,893	264,799
Market Cap Growth	-13.67%	4.59%	11.26%	10.73%	38.93%	60.48%
Enterprise Value	355,441	377,624	390,193	352,972	319,306	248,149
Last Close Price	72.30	72.57	67.85	62.76	59.14	41.46
PE Ratio	18.19	17.37	23.63	17.76	8.18	14.51
PS Ratio	5.85	5.40	7.12	6.33	4.11	6.00
PB Ratio	2.69	2.61	3.60	3.40	3.52	4.63
P/TBV Ratio	2.82	2.72	3.75	3.54	3.52	4.63
P/FCF Ratio	19.73	20.91	24.10	17.42	10.11	25.45
P/OCF Ratio	16.43	17.34	20.33	15.37	9.32	19.48
EV/Sales Ratio	4.52	4.30	6.13	5.49	3.57	5.62
EV/EBITDA Ratio	14.68	13.19	17.28	12.51	6.18	12.25
EV/EBIT Ratio	16.84	14.73	19.00	13.37	6.37	13.04
EV/FCF Ratio	15.80	16.66	20.75	15.09	8.78	23.85
Debt / Equity Ratio	0.09	0.10	0.11	0.12	0.14	0.25
Debt / EBITDA Ratio	0.62	0.63	0.60	0.52	0.29	0.69
Debt / FCF Ratio	0.64	0.80	0.72	0.63	0.41	1.35
Asset Turnover	0.37	0.40	0.42	0.45	0.76	0.53
Inventory Turnover	2.46	2.51	2.51	2.37	2.74	2.26
Quick Ratio	3.19	3.86	4.82	4.16	2.98	2.86
Current Ratio	4.06	4.73	5.69	5.06	3.56	3.63
Return on Equity (ROE)	15.19%	15.95%	16.26%	20.94%	54.21%	31.77%
Return on Assets (ROA)	6.16%	7.31%	8.49%	11.42%	26.39%	14.33%
Return on Capital (ROIC)	7.27%	8.49%	9.76%	13.31%	31.95%	17.95%
Return on Capital Employed (ROCE)	10.70%	12.30%	14.30%	19.20%	41.80%	25.30%
Earnings Yield	5.50%	5.76%	4.23%	5.63%	12.23%	6.89%
FCF Yield	5.07%	4.78%	4.15%	5.74%	9.89%	3.93%
Buyback Yield / Dilution	4.39%	-1.23%	-0.18%	-1.16%	2.52%	-0.44%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.